innovation, prescription drug pricing
2026 · 3rd Quarter (July 1 - Sep 30)
CRINETICS PHARMACEUTICALS
Filed by TARPLIN, DOWNS & YOUNG, LLC.
Open official filingSource-reported fields
Filing overview
- Type
- 3rd Quarter - Termination
- Posted
- Oct 20, 2026
- Income
- $60,000.00
- Expenses
- Not reported
- Registrant
- TARPLIN, DOWNS & YOUNG, LLC
- Filing UUID
- 52365a5c-3971-4b68-916c-1cdc4e94785b
- Termination date
- Sep 21, 2026
Literal source text
Lobbying issues and bill citations
Medicare policy
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.